Skip to content
Search

Latest Stories

Michelle Riddalls is PAGB's new chief executive

The consumer healthcare association PAGB has appointed Michelle Riddalls as its new chief executive.

Riddalls succeeds John Smith, who has led Proprietary Association of Great Britain since 2015.


The announcement comes in the wake of PAGB’s centenary year and as it embarks on a new five-year strategy focusing on selfcare and industry self-regulation.

Riddalls joined PAGB in 2019 from Pfizer, where she was director of regulatory affairs for its northern European cluster, and served PAGB as senior director of regulatory affairs and advertising services.

Neil Lister, PAGB's president, said: “The PAGB Board is delighted to appoint Michelle Riddalls as chief executive. Michelle has brought a wealth of regulatory experience to PAGB since joining us last year and is perfectly placed to lead the association as it enters its second century as the voice of the consumer healthcare industry.

“The industry has a vital role to play in enabling everyone to care for themselves and their families as effectively as possible – now more than ever, as we face the unprecedented health challenge that is Covid-19.”

Riddalls said: “For more than 100 years, PAGB has worked tirelessly and innovatively to ensure best practice and effective self-regulation in the consumer healthcare industry.

“I am committed to building on that heritage as we embark on the delivery of our new five-year strategy. This is an important time for our industry and I am looking forward to bringing my expertise and experience to my new role at PAGB.”

More For You

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
National Insurance Bill debated in the the House of Lords

National Insurance Bill debated in the the House of Lords

Lords back amendment to exempt pharmacies from national insurance hike

Pharmacies are expected to be exempted from national insurance contributions following an amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill, which was approved by the House of Lords on Tuesday, 25 February 2025.

In the 2024 Autumn Budget, Chancellor Rachel Reeves announced an increase in the employer secondary Class 1 National Insurance contributions rate, rising from 13.8% to 15% starting in April 2025.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less
GPhC Updates Pharmacy Education Guidance to Promote Sustainability

Pharmacies and registrants encouraged to adopt sustainable practices

gettyimages

GPhC updates education guidance to foster ‘greener’ thinking among pharmacists


The General Pharmaceutical Council (GPhC) has updated its guidance for the education and training of pharmacists and pharmacist independent prescribers to integrate environmentally sustainable practices into their curriculums.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less